BIT has better prospects IMO:
Sydney - Thursday - September 8: (RWE Aust Business News) -
Biotron Ltd (ASX:BIT) has had a lead compound selected for clinical
trials in HIV treatment.
The trials of the selected drug BIT225 are expected to commence
in the first half of 2006.
Biotron shares were up 3c at 19c
CTF
citrofresh international limited
BIT has better prospects IMO: Sydney - Thursday - September 8:...
Add to My Watchlist
What is My Watchlist?